What are the reliable ways to purchase Ivosidenib currently?

Ivosidenib is a targeted treatment drug for IDH1 mutation-positive tumors. It has been officially launched in China and has become one of the important choices for the treatment of related hematological tumors. Although it has been approved domestically, since it has not been included in medical insurance, its price is relatively high, and the monthly medication cost is usually around 30,000 to 40,000 yuan. If patients need to purchase, it is recommended to give priority to regular hospitals and authorized pharmacy channels to ensure the quality and safety of the drugs.

To purchase ivonib in China, patients should first contact a tertiary-level hospital or specialized hospital with qualifications for the diagnosis and treatment of hematological tumors. Hospital pharmacies can usually provide genuine ivonib, and doctors will prescribe it according to the patient's condition. Due to the high price, patients can consult the hospital pharmacist in detail about the medication plan and price, as well as learn about possible medication guidance and precautions. In addition, some cities and hospitals offer medication assistance programs or patient support programs to help qualifying patients reduce their financial burden.

In contrast, the generic drug market abroad, especially in Southeast Asia, provides more affordable options. Taking generic drugs in Laos as an example, their price is about more than 3,000 yuan, which is far lower than the price of domestic original drugs. The generic ivonib produced in Laos is basically the same as the original drug in terms of ingredients and efficacy. Some patients and agents will purchase it through regular overseas pharmacies or cross-border medical services. However, when purchasing, you need to pay special attention to the legality of the channels and the quality assurance of the drugs to avoid buying fake and shoddy products.

Generally speaking, the formal purchase channels of ivonib are mainly divided into domestic hospital pharmacies and overseas formal channels. Patients and their families should weigh price, medication safety and legal compliance when choosing. It is recommended to consult professional doctors and pharmacists first to avoid blind purchases. With the gradual advancement of medical insurance policies, the accessibility and price of ivonib are expected to improve in the future, bringing good news to more patients.

Reference link:https://www.tibsovo.com/